15
Participants
Start Date
June 30, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
March 31, 2013
XERECEPT
BID dosing, subcutaneous for 1 year
Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago
Dana-Farber Cancer Institute Pediatric Oncology, Boston
Lead Sponsor
Celtic Pharma Development Services
INDUSTRY